Tata Consultancy Services Ltd.

BSE: 532540 | NSE: TCS
Large Cap | IT - Software
2188.65
-0.25 (-0.01%)
< Home < Back

TCS Positioned as leader in Pharmacovigilance and Complaint Management Operations by Everest Group

Date: 20-07-2021

Tata Consultancy Services (TCS) has been positioned as a Leader in the Everest Group PEAK Matrix for Pharmacovigilance (PV) and Complaint Management Operations. According to the report, TCS is one of the fastest growing service providers within the pharmacovigilance market, and has accumulated significant scale across the pharmacovigilance value chain, including individual case study report (ICSR) case processing, literature screening, regulatory submission, aggregate reporting, and signal and risk management.

The report cites TCS’ strong capabilities to serve enterprises in both clinical trial drug candidates and post market surveillance products safety activities, as a key strength. It goes on to say that the company has made significant investments in technology to augment its services – leveraging cognitive automation for case processing and offering the TCS Advanced Drug Development (ADD) PV platform-driven services to its clientele.

TCS is an IT services, consulting and business solutions organization that has been partnering with many of the world’s largest businesses in their transformation journeys for over 50 years.